Rapid, Precise, and Clinically Relevant Quantification of Urinary Albumin and Creatinine Using a NanoDrop UV/Vis Spectrophotometer
Sensors · 2025
DOI: 10.3390/s25113307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sensors, 2025. Verfasst von Keith E Dias und 4 weiteren Autor:innen. Beteiligte Einrichtung: Monash Biospectroscopy Group, School of Chemistry, Monash University, Clayton, VIC 3800, Australia. Hauptthemen laut MEDLINE: Creatinine, Albuminuria. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Monash University, Australian Research Council Discovery Project.
Abstract (Originalsprache)
Albuminuria is a sensitive biomarker of kidney dysfunction, and the albumin/creatinine ratio (ACR) is an essential measure for monitoring diabetic kidney disease (DKD). Abnormal levels can indicate a propensity for progressive renal failure and other complications such as cardiovascular diseases. This study employed UV/Visible spectroscopy to analyze aqueous urine samples spiked with bovine serum albumin (BSA) and creatinine at clinically relevant concentrations (0–30 mg/L for albumin and 600–1800 mg/L for creatinine) using a multivariate method. UV/Visible spectra of co-spiked samples recorded in triplicate revealed distinct bands at 229 nm and 249 nm, corresponding to BSA and creatinine, respectively, alongside other amino acid bands. Partial Least Squares Regression (PLS-R) analysis for BSA yielded a Root Mean Square Error of Calibration (RMSEC) and Cross-Validation (RMSECV) values of 66.93 and 73.92 mg/L, respectively. For creatinine, RMSEC and RMSECV values were 244.32 and 275.65 mg/L, respectively. Prediction models for both BSA and creatinine compared to ELISA demonstrated a robust performance with R2PRED values of 0.96 and 0.95, respectively, indicating strong model reliability. The Limit of Detection (LOD) for co-spiked samples was 19.82 mg/L for BSA and 58.43 mg/L for creatinine. The significance of the achieved Limit of Detection (LOD) lies in its ability to measure concentrations well below the normal physiological ranges of 0–30 mg/L for albumin and 600–1800 mg/L for creatinine. These results demonstrate the proof of concept of applying an UV/Visible-spectroscopy-based method as a rapid, cost-effective point-of-care (PoC) tool for ACR measurements, offering promising applications in the early diagnosis, monitoring, and prognosis of diabetic kidney disease and associated cardiovascular complications. The next stage will involve a pilot trial to evaluate the technology’s potential using clinical patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Monash Biospectroscopy Group, School of Chemistry, Monash University, Clayton, VIC 3800, Australia.
- Department of Diabetes, School of Translational Medicine, Monash University, Melbourne, VIC 3004, Australia.
- German Diabetes Centre, Institute for Clinical Diabetology, Leibniz Centre for Diabetes Research at Heinrich Heine University, 40225 Dusseldorf, Germany.
ORCID-Profile: Jay C Jha, Karin Jandeleit-Dahm, Bayden R Wood
Förderung
- Monash University
- Australian Research Council Discovery Project
Zitieren
APA
Dias, K. E., Sourris, K. C., Jha, J. C., Jandeleit-Dahm, K., & Wood, B. R. (2025). Rapid, Precise, and Clinically Relevant Quantification of Urinary Albumin and Creatinine Using a NanoDrop UV/Vis Spectrophotometer. Sensors. https://doi.org/10.3390/s25113307
Vancouver
Dias KE, Sourris KC, Jha JC, Jandeleit-Dahm K, Wood BR. Rapid, Precise, and Clinically Relevant Quantification of Urinary Albumin and Creatinine Using a NanoDrop UV/Vis Spectrophotometer. Sensors. 2025. doi:10.3390/s25113307
BibTeX
@article{Dias2025,
author = {Dias, Keith E and Sourris, Karly C and Jha, Jay C and Jandeleit-Dahm, Karin and Wood, Bayden R},
title = {Rapid, Precise, and Clinically Relevant Quantification of Urinary Albumin and Creatinine Using a NanoDrop UV/Vis Spectrophotometer},
journal = {Sensors},
year = {2025},
doi = {10.3390/s25113307}
}
EUVIMED